Bone Marrow Transplantation Market

Bone Marrow Transplantation Market Study by Autologous and Allogeneic Bone Marrow Transplantation for Leukemia, Lymphoma, Myeloma, Myelodysplasia, Myeloproliferative and Others from 2024 to 2034

Analysis of Bone Marrow Transplantation Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Bone Marrow Transplantation Market Outlook (2024 to 2034)

The global bone marrow transplantation market size is set to account for a valuation of US$ 11.17 billion in 2024 and is projected to expand at 3.7% CAGR through 2034. As a result, worldwide revenue from bone marrow transplantation is projected reach US$ 16 billion by 2034-end.

As the name suggests, bone marrow transplantation is the process of replacing the existing damaged or disease-affected bone marrow with healthy stem cells. These cells are usually derived from another donor with a similar genetic profile or taken from the peripheral blood or umbilical cord blood of the patient.

Surging incidence of leukemia and other types of blood cancers around the world is the primary aspect that is forecasted to uplift the demand for bone marrow transplantation over the next 10 years. Growing prevalence of Hodgkin lymphoma, myeloma, non-Hodgkin lymphoma, and thalassemia is also estimated to contribute to the steadily increasing bone marrow transplantation market size.

  • Bone marrow transplantation for the treatment of leukemia is forecasted to account for a market valuation of US$ 3.9 billion by the end of 2034.

Advancements in stem cell technology, wide availability of novel stem cell therapies, rising investments in blood cancer R&D, growing awareness regarding the benefits of bone marrow transplant, and increasing per capita healthcare expenditure are other factors that could cushion demand for bone marrow transplantation devices and services going forward.

High costs associated with bone marrow transplantation procedures and the shortage of bone marrow donors are projected to be key bone marrow transplantation market trends that impede global revenue generation in the long run. The rapidly expanding geriatric population around the world is also estimated to boost bone marrow transplantation market growth through 2034.

Report Attributes Details
Bone Marrow Transplantation Market Size (2024E) US$ 11.17 Billion
Projected Market Value (2034F) US$ 16 Billion
Global Market Growth Rate (2024 to 2034) 3.7% CAGR
China Market Value (2034F) US$ 599.2 Million
Canada Market Growth Rate (2024 to 2034) 4.2% CAGR
North America Market Share (2024E) 33.1%
Autologous Bone Marrow Transplantation Demand Growth (2024 to 2034) 3.3% CAGR
East Asia Market Value (2034F) US$ 1.48 Billion
Key Companies Profiled
  • Merck Millipore Corporation
  • ATCC Inc.
  • Sanofi-Aventis LLC
  • Cellular Dynamics International
  • STEMCELL Technologies
  • PromoCell GmbH
  • American Type Culture Collection (ATCC) Inc.
  • ReeLabs Pvt. Ltd.
  • Mesoblast Ltd.
  • HemaCare

Don't Need a Global Report?

save 40%! on Country & Region specific reports

How Can Start-ups Revolutionize the Bone Marrow Transplantation Landscape?

“Focus on Development of Advanced Monitoring Solutions to Improve Patient Outcomes”

Bone marrow transplantation is a complex and long process, which is why patient monitoring in the pre and post-surgery stages is of the essence. New companies looking to enter the bone marrow transplant space are focusing on providing advanced monitoring solutions to improve patient outcomes from bone marrow transplantation surgeries.

  • In November 2023, BioIntelliSense, a new company founded in 2018 providing health monitoring and clinical intelligence solutions along with UC Davis Health, announced the launch of a new continuous monitoring program for bone marrow transplant patients. The program incorporates the use of BioButton wearable devices to monitor subtle changes in vital signs and identify the signs of patient deterioration to promote better clinical decision-making.

Surging adoption of stem cell therapies in bone marrow transplantation and the growing popularity of regenerative medicine are opening up avenues of opportunities for new companies. Bone marrow transplant providers are focusing on raising capital to finance their research and compete with established market players.

  • In September 2021, Garuda Therapeutics, a start-up focusing on eliminating the dependency on blood stem cell transplants, announced its launch with a Series A funding round of US$ 72 million. The oversubscribed financing round was led by Orbimed, Aisling Capital, and Northpond Ventures with participation from other investors.

Start-ups can gain a detailed understanding of factors such as local supply, pricing trends, product standards, safety regulations, and new developments from this bone marrow transplantation market research report by skilled analysts at Fact.MR, a market research and competitive intelligence provider.

Country-wise Insights

High prevalence of blood cancers and a growing geriatric population are estimated to be common prospects that drive bone marrow transplantation demand in countries such as India, China, the United States, Japan, Germany, Italy, and Australia over the next 10 years and beyond.

What Makes the United States a Key Market for Bone Marrow Transplant Providers?

“Increasing Geriatric Population and Presence of Well-established Healthcare Infrastructure”

Attribute United States
Market Value (2024E) US$ 3.45 Billion
Growth Rate (2024 to 2034) 4.1% CAGR
Projected Value (2034F) US$ 5.17 Billion

Developed healthcare infrastructure of the United States coupled with high healthcare spending potential offers a fertile ground for bone marrow transplantation companies to boost their business. The increasing senescent population of the United States is also projected to drive demand for bone marrow transplantation services as older people are more inclined to need bone transplants as compared to younger people.

Presence of key bone marrow transplantation providers and rapid adoption of advanced therapies and treatments is projected to enable the United States to hold a prominent chunk of the North American bone marrow transplantation market by 2034.

Why Should Bone Marrow Transplantation Providers Target India?

“High Incidence of Blood Cancers and Sickle Cell Anemia”

The tribal population of India is at a high risk of sickle cell anemia, and this is projected to augment demand for bone marrow transplantation in the country over the coming years. The Indian government is making several efforts to manage the incidence of sickle cell anemia by launching different screening and awareness programs in the country.

  • In July 2023, the Prime Minister of India announced the launch of a sickle cell anemia elimination mission that was aimed at screening young tribals in the country. This mission is part of the Indian government’s plan to eradicate sickle cell anemia in the country by 2047.

Increasing availability of novel bone marrow transplantation procedures and growing healthcare expenditure are also projected to create new opportunities for bone marrow transplantation companies in India over the forecast period.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Category-wise Insights

Bone marrow transplant providers are focusing on providing allogeneic transplants in hospital settings to maximize their revenue generation across the study period and beyond.

Which Type of Bone Marrow Transplant Accounts for High Revenue Streams?

“Growing Demand for Allogeneic Bone Marrow Transplant Due to Higher Success Rate”

Attribute Allogeneic Bone Marrow Transplantation
Segment Value (2024E) US$ 7.36 Billion
Growth Rate (2024 to 2034) 3.8% CAGR
Projected Value (2034F) US$ 10.71 Billion

An allogeneic bone marrow transplant is a type of transplantation procedure where the donor shares the same genetic type as the patient. Usually, this type of transplant involves familial donors such as brothers and sisters. In this type of transplantation, the transplanted graft is free from any contamination or disease, which is why it has a better success rate as compared to autologous bone marrow transplantation. All of the aforementioned factors contribute to the dominant market share of allogeneic bone marrow transplantation.

Where are Most Bone Marrow Transplants Performed?

“Hospitals Account for Leading Market Share Due to Comprehensive Post-Procedure Care”

Attribute Hospitals
Segment Value (2024E) US$ 10.35 Billion
Growth Rate (2024 to 2034) 3.7% CAGR
Projected Value (2034F) US$ 14.83 Billion

Bone marrow transplantation is a complex procedure that requires skilled medical professionals and advanced medical devices. Both of the requisites are met in a hospital setting, and this is why most patients get their bone marrow transplantation procedures done in hospitals around the world. Better post-procedure care and improved patient outcomes are also factors that contribute to a higher number of bone marrow transplantation surgeries being performed in hospitals as compared to other healthcare establishments.

Competitive Landscape

Bone marrow transplantation service providers are projected to benefit from supportive government initiatives that are being launched to increase awareness about bone marrow transplants and other related diseases such as leukemia, lymphoma, and thalassemia.

  • In October 2023, the American Oncology Institute, a renowned cancer care provider in the South Asian region, announced the launch of its bone marrow transplantation program in India. The company aims to bolster its services in India on the back of the rising incidence of different types of cancers, which is pushing the demand for bone marrow transplantation services.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Key Segments of Bone Marrow Transplantation Market Research

  • By Transplant Type:

    • Autologous Bone Marrow Transplantation
    • Allogeneic Bone Marrow Transplantation
  • By Indication:

    • Leukemia
    • Lymphoma
    • Myeloma
    • Myelodysplasia
    • Myeloproliferative Neoplasms
    • Aplastic Anemia
    • Solid Tumors
    • Sickle Cell Anemia
    • Thalassemia
    • Others
  • By End User:

    • Hospitals
    • Multispecialty Clinics
    • Ambulatory Surgical Centers
  • By Region:

    • North America
    • Latin America
    • Europe
    • East Asia
    • South Asia & Oceania
    • Middle East & Africa

Table of Content

1. Global Market - Executive Summary

    1.1. Global Market Overview

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Fact.MR Analysis and Recommendations

2. Global Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Introduction and Definition

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Impact Benchmark with Previous Crisis

            3.1.1.1. Change in Demand

            3.1.1.2. Before and After COVID-19 Crisis (Projected)

            3.1.1.3. Before and After Sub-prime Crisis – 2008 (Actual)

            3.1.1.4. Change in Demand post Recovery Period (After Each Crisis)

        3.1.2. Impact on Market and Value (US$ Mn)

            3.1.2.1. Likely Loss of Value in 2023

            3.1.2.2. Mid-term and Long-term Forecasts

            3.1.2.3. Quarter by Quarter Demand and Recovery Assessment

        3.1.3. Anticipated Demand and Value Recovery Curve

            3.1.3.1. Likelihood of U-Shape Recovery

            3.1.3.2. Likelihood of L-Shape Recovery

        3.1.4. Recovery Period Assessment by Key Countries

        3.1.5. Recovery Assessment by Key Market Segments

        3.1.6. Action Points and Recommendations for Suppliers

        3.1.7. Impact on Trade Balance

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Transplant Type Development Trends

4. Market Background and Foundation Data Points

    4.1. Need of the Hour for Industries

    4.2. Industry Wise Industry 4.0

    4.3. – Strategic Priorities

    4.4. Life Cycle Stage

    4.5. Importance of Technology

    4.6. Use Cases of Bone Marrow Transplantation

    4.7. Forecast Factors: Relevance and Impact

    4.8. Investment Feasibility Matrix

    4.9. PESTLE Analysis

    4.10. Porter’s Five Forces Analysis

    4.11. Market Dynamics

        4.11.1. Drivers

        4.11.2. Restraints

        4.11.3. Opportunity Analysis

        4.11.4. Trend

5. Global Market Demand (US$ Mn) Analysis 2018 to 2023 and Forecast, 2024 to 2034

    5.1. Historical Market Value (US$ Mn) Analysis, 2018 to 2023

    5.2. Current and Future Market Value (US$ Mn) Projections, 2024 to 2034

        5.2.1. Y-o-Y Growth Trend Analysis

        5.2.2. Absolute $ Opportunity Analysis

6. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Transplant Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Value (US$ Mn) Analysis By Transplant Type, 2018 to 2023

    6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Transplant Type, 2024 to 2034

        6.3.1. Autologous Bone Marrow Transplantation

        6.3.2. Allogeneic Bone Marrow Transplantation

    6.4. Market Attractiveness Analysis By Transplant Type

7. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Indication

    7.1. Introduction / Key Findings

    7.2. Historical Market Value (US$ Mn) Analysis By Indication, 2018 to 2023

    7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Indication, 2024 to 2034

        7.3.1. Leukemia

        7.3.2. Lymphoma

        7.3.3. Myeloma

        7.3.4. Myelodysplasia

        7.3.5. Myeloproliferative Neoplasms

        7.3.6. Aplastic Anemia

        7.3.7. Solid Tumors

        7.3.8. Sickle Cell Anemia

        7.3.9. Thalassemia

        7.3.10. Others

    7.4. Market Attractiveness Analysis By Indication

8. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by End User

    8.1. Introduction / Key Findings

    8.2. Historical Market Value (US$ Mn) Analysis By End User, 2018 to 2023

    8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By End User, 2024 to 2034

        8.3.1. Hospitals

        8.3.2. Multispecialty Clinics

        8.3.3. Ambulatory Surgical Centers

    8.4. Market Attractiveness Analysis By End User

9. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region

    9.1. Introduction / Key Findings

    9.2. Historical Market Value (US$ Mn) Analysis By Region, 2018 to 2023

    9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024 to 2034

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. East Asia

        9.3.5. South Asia & Oceania

        9.3.6. Middle East and Africa (MEA)

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034

    10.1. Introduction / Key Findings

    10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023

    10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034

        10.3.1. By Country

            10.3.1.1. United States

            10.3.1.2. Canada

        10.3.2. By Transplant Type

        10.3.3. By Indication

    10.4. Market Attractiveness Analysis

        10.4.1. By Country

        10.4.2. By Transplant Type

        10.4.3. By Indication

11. Latin America Market Analysis 2018 to 2023 and Forecast 2024 to 2034

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023

    11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024 to 2034

        11.3.1. By Country

            11.3.1.1. Brazil

            11.3.1.2. Mexico

            11.3.1.3. Rest of Latin America

        11.3.2. By Transplant Type

        11.3.3. By Indication

        11.3.4. By End User

    11.4. Market Attractiveness Analysis

        11.4.1. By Country

        11.4.2. By Transplant Type

        11.4.3. By Indication

        11.4.4. By End User

12. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023

    12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024 to 2034

        12.3.1. By Country

            12.3.1.1. Germany

            12.3.1.2. France

            12.3.1.3. Italy

            12.3.1.4. Spain

            12.3.1.5. United Kingdom

            12.3.1.6. BENELUX

            12.3.1.7. Russia

            12.3.1.8. Rest of Europe

        12.3.2. By Transplant Type

        12.3.3. By Indication

        12.3.4. By End User

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Transplant Type

        12.4.3. By Indication

        12.4.4. By End User

13. East Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023

    13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024 to 2034

        13.3.1. By Country

            13.3.1.1. China

            13.3.1.2. Japan

            13.3.1.3. South Korea

        13.3.2. By Transplant Type

        13.3.3. By Indication

        13.3.4. By End User

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Transplant Type

        13.4.3. By Indication

        13.4.4. By End User

14. South Asia & Oceania Market Analysis 2018 to 2023 and Forecast 2024 to 2034

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023

    14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024 to 2034

        14.3.1. By Country

            14.3.1.1. India

            14.3.1.2. Thailand

            14.3.1.3. Malaysia

            14.3.1.4. Singapore

            14.3.1.5. Vietnam

            14.3.1.6. ANZ

            14.3.1.7. Rest of South Asia & Oceania

        14.3.2. By Transplant Type

        14.3.3. By Indication

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Transplant Type

        14.4.3. By Indication

        14.4.4. By End User

15. Middle East and Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034

    15.1. Introduction / Key Findings

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023

    15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024 to 2034

        15.3.1. By Country

            15.3.1.1. GCC Countries

            15.3.1.2. South Africa

            15.3.1.3. Israel

            15.3.1.4. Rest of Middle East and Africa (MEA)

        15.3.2. By Transplant Type

        15.3.3. By Indication

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Transplant Type

        15.4.3. By Indication

        15.4.4. By End User

16. Market Structure Analysis

    16.1. Market Analysis by Tier of Companies

    16.2. Market Concentration

    16.3. Market Share Analysis of Top Players

    16.4. Market Presence Analysis

17. Competition Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Competition Deep Dive

    17.4. Merck Millipore Corporation

        17.4.1. Company Overview

        17.4.2. Transplant Type overview

        17.4.3. SWOT Analysis

        17.4.4. Key Developments

    17.5. ATCC Inc.

    17.6. Sanofi-Aventis LLC

    17.7. Cellular Dynamics International

    17.8. STEMCELL Technologies

    17.9. PromoCell GmbH

    17.10. American Type Culture Collection (ATCC) Inc.

    17.11. ReeLabs Pvt. Ltd.

    17.12. Mesoblast Ltd.

    17.13. HemaCare

18. Assumptions and Acronyms Used

19. Research Methodology

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 1: Global Market Value (US$ Mn) Analysis, by Transplant Type, 2018 to 2023

Table 2: Global Market Value (US$ Mn) Analysis, by Transplant Type, 2024 to 2034

Table 3: Global Market Value (US$ Mn) Opportunity Analysis, by Transplant Type, 2024 to 2034

Table 4: Global Market Value (US$ Mn) Analysis, by Indication, 2018 to 2023

Table 5: Global Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034

Table 6: Global Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034

Table 7: Global Market Value (US$ Mn) Analysis, by End User, 2018 to 2023

Table 8: Global Market Value (US$ Mn) Analysis, by End User, 2024 to 2034

Table 9: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034

Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2023

Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034

Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034

Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 2023

Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034

Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034

Table 16: North America Market Value (US$ Mn) Analysis, by Transplant Type, 2018 to 2023

Table 17: North America Market Value (US$ Mn) Analysis, by Transplant Type, 2024 to 2034

Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Transplant Type, 2024 to 2034

Table 19: North America Market Value (US$ Mn) Analysis, by Indication, 2018 to 2023

Table 20: North America Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034

Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034

Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2018 to 2023

Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034

Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034

Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 2023

Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034

Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034

Table 28: Latin America Market Value (US$ Mn) Analysis, by Transplant Type, 2018 to 2023

Table 29: Latin America Market Value (US$ Mn) Analysis, by Transplant Type, 2024 to 2034

Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Transplant Type, 2024 to 2034

Table 31: Latin America Market Value (US$ Mn) Analysis, by Indication, 2018 to 2023

Table 32: Latin America Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034

Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034

Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2018 to 2023

Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034

Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034

Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 2023

Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034

Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034

Table 40: Europe Market Value (US$ Mn) Analysis, by Transplant Type, 2018 to 2023

Table 41: Europe Market Value (US$ Mn) Analysis, by Transplant Type, 2024 to 2034

Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Transplant Type, 2024 to 2034

Table 43: Europe Market Value (US$ Mn) Analysis, by Indication, 2018 to 2023

Table 44: Europe Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034

Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034

Table 46: Europe Market Value (US$ Mn) Analysis, by End User, 2018 to 2023

Table 47: Europe Market Value (US$ Mn) Analysis, by End User, 2024 to 2034

Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034

Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018 to 2023

Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034

Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034

Table 52: East Asia Market Value (US$ Mn) Analysis, by Transplant Type, 2018 to 2023

Table 53: East Asia Market Value (US$ Mn) Analysis, by Transplant Type, 2024 to 2034

Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Transplant Type, 2024 to 2034

Table 55: East Asia Market Value (US$ Mn) Analysis, by Indication, 2018 to 2023

Table 56: East Asia Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034

Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034

Table 58: East Asia Market Value (US$ Mn) Analysis, by End User, 2018 to 2023

Table 59: East Asia Market Value (US$ Mn) Analysis, by End User, 2024 to 2034

Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034

Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018 to 2023

Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2024 to 2034

Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034

Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Transplant Type, 2018 to 2023

Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Transplant Type, 2024 to 2034

Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Transplant Type, 2024 to 2034

Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Indication, 2018 to 2023

Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034

Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034

Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2018 to 2023

Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2024 to 2034

Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034

Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 2023

Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034

Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034

Table 76: MEA Market Value (US$ Mn) Analysis, by Transplant Type, 2018 to 2023

Table 77: MEA Market Value (US$ Mn) Analysis, by Transplant Type, 2024 to 2034

Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Transplant Type, 2024 to 2034

Table 79: MEA Market Value (US$ Mn) Analysis, by Indication, 2018 to 2023

Table 80: MEA Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034

Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034

Table 82: MEA Market Value (US$ Mn) Analysis, by End User, 2018 to 2023

Table 83: MEA Market Value (US$ Mn) Analysis, by End User, 2024 to 2034

Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 1: Global Market Value (US$ Mn) Historical Analysis, 2018 to 2023

Figure 2: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034

Figure 3: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2034

Figure 4: Global Market Incremental $ Opportunity, 2024 to 2034

Figure 5: Global Market Share and BPS Analysis by Transplant Type, 2024 & 2034

Figure 6: Global Market Y-o-Y Growth Projections by Transplant Type, 2024 to 2034

Figure 7: Global Market Attractiveness Analysis by Transplant Type, 2024 to 2034

Figure 8: Global Market Share and BPS Analysis by Indication, 2024 & 2034

Figure 9: Global Market Y-o-Y Growth Projections by Indication, 2024 to 2034

Figure 10: Global Market Attractiveness Analysis by Indication, 2024 to 2034

Figure 11: Global Market Share and BPS Analysis by End User, 2024 & 2034

Figure 12: Global Market Y-o-Y Growth Projections by End User, 2024 to 2034

Figure 13: Global Market Attractiveness Analysis by End User, 2024 to 2034

Figure 14: Global Market Share and BPS Analysis by Region, 2024 & 2034

Figure 15: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034

Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034

Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2018 to 2023

Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034

Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2034

Figure 20: North America Market Incremental $ Opportunity, 2024 to 2034

Figure 21: North America Market Share Analysis by Country, 2024 & 2034

Figure 22: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034

Figure 23: North America Market Attractiveness Analysis by Country, 2024 to 2034

Figure 24: North America Market Share and BPS Analysis by Transplant Type, 2024 & 2034

Figure 25: North America Market Y-o-Y Growth Projections by Transplant Type, 2024 to 2034

Figure 26: North America Market Attractiveness Analysis by Transplant Type, 2024 to 2034

Figure 27: North America Market Share and BPS Analysis by Indication, 2024 & 2034

Figure 28: North America Market Y-o-Y Growth Projections by Indication, 2024 to 2034

Figure 29: North America Market Attractiveness Analysis by Indication, 2024 to 2034

Figure 30: North America Market Share and BPS Analysis by End User, 2024 & 2034

Figure 31: North America Market Y-o-Y Growth Projections by End User, 2024 to 2034

Figure 32: North America Market Attractiveness Analysis by End User, 2024 to 2034

Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2018 to 2023

Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034

Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2018 to 2034

Figure 36: Latin America Market Incremental $ Opportunity, 2024 to 2034

Figure 37: Latin America Market Share Analysis by Country, 2024 & 2034

Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034

Figure 39: Latin America Market Attractiveness Analysis by Country, 2024 to 2034

Figure 40: Latin America Market Share and BPS Analysis by Transplant Type, 2024 & 2034

Figure 41: Latin America Market Y-o-Y Growth Projections by Transplant Type, 2024 to 2034

Figure 42: Latin America Market Attractiveness Analysis by Transplant Type, 2024 to 2034

Figure 43: Latin America Market Share and BPS Analysis by Indication, 2024 & 2034

Figure 44: Latin America Market Y-o-Y Growth Projections by Indication, 2024 to 2034

Figure 45: Latin America Market Attractiveness Analysis by Indication, 2024 to 2034

Figure 46: Latin America Market Share and BPS Analysis by End User, 2024 & 2034

Figure 47: Latin America Market Y-o-Y Growth Projections by End User, 2024 to 2034

Figure 48: Latin America Market Attractiveness Analysis by End User, 2024 to 2034

Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2018 to 2023

Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034

Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2018 to 2034

Figure 52: Europe Market Incremental $ Opportunity, 2024 to 2034

Figure 53: Europe Market Share Analysis by Country, 2024 & 2034

Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034

Figure 55: Europe Market Attractiveness Analysis by Country, 2024 to 2034

Figure 56: Europe Market Share and BPS Analysis by Transplant Type, 2024 & 2034

Figure 57: Europe Market Y-o-Y Growth Projections by Transplant Type, 2024 to 2034

Figure 58: Europe Market Attractiveness Analysis by Transplant Type, 2024 to 2034

Figure 59: Europe Market Share and BPS Analysis by Indication, 2024 & 2034

Figure 60: Europe Market Y-o-Y Growth Projections by Indication, 2024 to 2034

Figure 61: Europe Market Attractiveness Analysis by Indication, 2024 to 2034

Figure 62: Europe Market Share and BPS Analysis by End User, 2024 & 2034

Figure 63: Europe Market Y-o-Y Growth Projections by End User, 2024 to 2034

Figure 64: Europe Market Attractiveness Analysis by End User, 2024 to 2034

Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2018 to 2023

Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034

Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2018 to 2034

Figure 68: East Asia Market Incremental $ Opportunity, 2024 to 2034

Figure 69: East Asia Market Share Analysis by Country, 2024 & 2034

Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034

Figure 71: East Asia Market Attractiveness Analysis by Country, 2024 to 2034

Figure 72: East Asia Market Share and BPS Analysis by Transplant Type, 2024 & 2034

Figure 73: East Asia Market Y-o-Y Growth Projections by Transplant Type, 2024 to 2034

Figure 74: East Asia Market Attractiveness Analysis by Transplant Type, 2024 to 2034

Figure 75: East Asia Market Share and BPS Analysis by Indication, 2024 & 2034

Figure 76: East Asia Market Y-o-Y Growth Projections by Indication, 2024 to 2034

Figure 77: East Asia Market Attractiveness Analysis by Indication, 2024 to 2034

Figure 78: East Asia Market Share and BPS Analysis by End User, 2024 & 2034

Figure 79: East Asia Market Y-o-Y Growth Projections by End User, 2024 to 2034

Figure 80: East Asia Market Attractiveness Analysis by End User, 2024 to 2034

Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2018 to 2023

Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034

Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2018 to 2034

Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2024 to 2034

Figure 85: South Asia & Oceania Market Share Analysis by Country, 2024 & 2034

Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2024 to 2034

Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2024 to 2034

Figure 88: South Asia & Oceania Market Share and BPS Analysis by Transplant Type, 2024 & 2034

Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Transplant Type, 2024 to 2034

Figure 90: South Asia & Oceania Market Attractiveness Analysis by Transplant Type, 2024 to 2034

Figure 91: South Asia & Oceania Market Share and BPS Analysis by Indication, 2024 & 2034

Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Indication, 2024 to 2034

Figure 93: South Asia & Oceania Market Attractiveness Analysis by Indication, 2024 to 2034

Figure 94: South Asia & Oceania Market Share and BPS Analysis by End User, 2024 & 2034

Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by End User, 2024 to 2034

Figure 96: South Asia & Oceania Market Attractiveness Analysis by End User, 2024 to 2034

Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2018 to 2023

Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034

Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2018 to 2034

Figure 100: MEA Market Incremental $ Opportunity, 2024 to 2034

Figure 101: MEA Market Share Analysis by Country, 2024 & 2034

Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034

Figure 103: MEA Market Attractiveness Analysis by Country, 2024 to 2034

Figure 104: MEA Market Share and BPS Analysis by Transplant Type, 2024 & 2034

Figure 105: MEA Market Y-o-Y Growth Projections by Transplant Type, 2024 to 2034

Figure 106: MEA Market Attractiveness Analysis by Transplant Type, 2024 to 2034

Figure 107: MEA Market Share and BPS Analysis by Indication, 2024 & 2034

Figure 108: MEA Market Y-o-Y Growth Projections by Indication, 2024 to 2034

Figure 109: MEA Market Attractiveness Analysis by Indication, 2024 to 2034

Figure 110: MEA Market Share and BPS Analysis by End User, 2024 & 2034

Figure 111: MEA Market Y-o-Y Growth Projections by End User, 2024 to 2034

Figure 112: MEA Market Attractiveness Analysis by End User, 2024 to 2034

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

- FAQs -

How big is the bone marrow transplantation market?

The global bone marrow transplantation market is estimated at US$ 11.17 billion in 2024.

What is the demand projection for bone marrow transplantation solutions for 2034?

Demand for bone marrow transplantation is forecasted to reach a market value of US$ 16 billion by 2034-end.

At what rate are the sales of bone marrow transplantation services forecasted to rise?

Sales of bone marrow transplantation services are set to rise at a slow 3.7% CAGR through 2034.

Which region accounts for high demand for bone marrow transplantation?

The market in North America is predicted to increase at a CAGR of 4.1% from 2024 to 2034.

Which type of bone marrow transplantation is highly popular?

Allogeneic bone marrow transplantation is widely adopted for the treatment several indications.

Who are the top bone marrow transplantation providers?

Merck Millipore Corporation, ATCC Inc., Sanofi-Aventis LLC, PromoCell GmbH, ReeLabs Pvt. Ltd., Mesoblast Ltd., and HemaCare are key companies in the market.

- Also of Interest -

Bone Void Filler Market

Bone Void Filler Market Study by Demineralized Bones, Calcium Sulphate, Calcium Phosphate, and Tri Calcium Phosphate for Hospitals, Ambulatory Surgical Centers, and Clinics from 2024 to 2034

Bone Grafts and Substitutes Market

Bone Grafts and Substitutes Market Analysis By Product (Allografts, Synthetic Bone Grafts), By Material (Ceramic-based, Polymer-based, Growth Factor-based, Cell-based), By End User, By Region - Global Market Insights 2021-2028

Bone Biopsy Systems Market

Bone Biopsy Systems Market By Use Case (Bone Marrow Biopsy, Bone Lesion Biopsy), By Diagnostic Application (Bone Disorder Diagnosis, Bone Cancer Diagnosis, Bone Infection Detection, Chronic Kidney Disease Diagnosis), By End User, By Region - Global Insights 2022 to 2032

Blood Cancer Diagnostics Market

Blood Cancer Diagnostics Market By Test (CBC Tests for Blood Cancer Diagnostics, CTC Tests, Blood Protein Testing, Liquid Biopsy, Bone Marrow Biopsy), By End User, By Region - Global Market Insights 2022–2032

Bone Marrow Transplantation Market

Schedule a Call